135 related articles for article (PubMed ID: 24374271)
1. Bifunctional thiosialosides inhibit influenza virus.
Yang Y; He Y; Li X; Dinh H; Iyer SS
Bioorg Med Chem Lett; 2014 Jan; 24(2):636-43. PubMed ID: 24374271
[TBL] [Abstract][Full Text] [Related]
2. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T
J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors.
Suzuki K; Koyama T; Yingsakmongkon S; Suzuki Y; Hatano K; Matsuoka K
Bioorg Med Chem; 2012 Jan; 20(1):446-54. PubMed ID: 22100261
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
5. New adamantane derivatives can overcome resistance of influenza A(H1N1)pdm2009 and A(H3N2) viruses to remantadine.
Shibnev VA; Garaev TM; Finogenova MP; Shevchenko ES; Burtseva EI
Bull Exp Biol Med; 2012 Jun; 153(2):233-5. PubMed ID: 22816091
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.
Lin C; Sun C; Liu X; Zhou Y; Hussain M; Wan J; Li M; Li X; Jin R; Tu Z; Zhang J
Antiviral Res; 2016 May; 129():13-20. PubMed ID: 26802557
[TBL] [Abstract][Full Text] [Related]
7. Anti-influenza A Virus Activity of Dendrobine and Its Mechanism of Action.
Li R; Liu T; Liu M; Chen F; Liu S; Yang J
J Agric Food Chem; 2017 May; 65(18):3665-3674. PubMed ID: 28417634
[TBL] [Abstract][Full Text] [Related]
8. Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.
Kumar N; Sharma NR; Ly H; Parslow TG; Liang Y
Antimicrob Agents Chemother; 2011 Dec; 55(12):5553-9. PubMed ID: 21930873
[TBL] [Abstract][Full Text] [Related]
9. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
[TBL] [Abstract][Full Text] [Related]
11. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
12. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
[TBL] [Abstract][Full Text] [Related]
13. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl alpha(2-->3) lactose moieties as inhibitors for human influenza viruses.
Oka H; Onaga T; Koyama T; Guo CT; Suzuki Y; Esumi Y; Hatano K; Terunuma D; Matsuoka K
Bioorg Med Chem; 2009 Aug; 17(15):5465-75. PubMed ID: 19589684
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology and spread of drug resistant human influenza viruses.
Hurt AC
Curr Opin Virol; 2014 Oct; 8():22-9. PubMed ID: 24866471
[TBL] [Abstract][Full Text] [Related]
16. Novel amides modified rupestonic acid derivatives as anti-influenza virus reagents.
Li G; Obul M; Zhao JY; Liu GY; Lu W; Aisa HA
Bioorg Med Chem Lett; 2019 Oct; 29(19):126605. PubMed ID: 31439378
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of human influenza A virus replication by chloroquine.
Ooi EE; Chew JS; Loh JP; Chua RC
Virol J; 2006 May; 3():39. PubMed ID: 16729896
[TBL] [Abstract][Full Text] [Related]
18. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.
Ilyushina NA; Donnelly RP
Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230
[TBL] [Abstract][Full Text] [Related]
19. A novel benzo-heterocyclic amine derivative N30 inhibits influenza virus replication by depression of Inosine-5'-Monophospate Dehydrogenase activity.
Hu J; Ma L; Wang H; Yan H; Zhang D; Li Z; Jiang J; Li Y
Virol J; 2017 Mar; 14(1):55. PubMed ID: 28298229
[TBL] [Abstract][Full Text] [Related]
20. Strain-specific antiviral activity of iminosugars against human influenza A viruses.
Hussain S; Miller JL; Harvey DJ; Gu Y; Rosenthal PB; Zitzmann N; McCauley JW
J Antimicrob Chemother; 2015 Jan; 70(1):136-52. PubMed ID: 25223974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
